News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
DRISCOLL FREDERICK W
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/12/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/28/2023 |
4
| DRISCOLL FREDERICK W (Director) has filed a Form 4 on Cellectar Biosciences, Inc.|
Txns:
| Granted 25,000 options to buy
@ $1.85, valued at
$46.3k
|
|
| 01/05/2023 |
4
| DRISCOLL FREDERICK W (Director) has filed a Form 4 on Cue Biopharma, Inc.|
Txns:
| Granted 10,000 options to buy
@ $2.66, valued at
$26.6k
|
|
| 08/01/2022 |
4
| DRISCOLL FREDERICK W (Director) has filed a Form 4 on Cellectar Biosciences, Inc.|
Txns:
| Granted 7,800 options to buy
@ $0 |
|
| 07/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/28/2022 |
4
| DRISCOLL FREDERICK W (CFO) has filed a Form 4 on Renovacor, Inc.|
Txns:
| Granted 155,325 options
@ $4.3, valued at
$667.9k
|
|
| 01/05/2022 |
4
| DRISCOLL FREDERICK W (Director) has filed a Form 4 on Cue Biopharma, Inc.|
Txns:
| Granted 10,000 options to buy
@ $12.28, valued at
$122.8k
|
|
| 11/19/2021 |
4
| DRISCOLL FREDERICK W (CFO) has filed a Form 4 on Flexion Therapeutics Inc|
Txns:
| Disposed/sold 30,680 shares
@ $8.5, valued at
$260.8k
Disposed/sold 168,000 options to buy
@ $8.35, valued at
$1.4M
|
|
| 09/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/06/2021 |
4
| DRISCOLL FREDERICK W (Director) has filed a Form 4 on MEI Pharma, Inc.|
Txns:
| Granted 50,000 options to buy
@ $2.95, valued at
$147.5k
|
|
| 07/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/03/2021 |
4
| DRISCOLL FREDERICK W (CFO) has filed a Form 4 on Flexion Therapeutics Inc|
Txns:
| Granted 28,000 shares
@ $0
Granted 168,000 options to buy
@ $8.35, valued at
$1.4M
|
|
| 02/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/06/2021 |
4
| DRISCOLL FREDERICK W (Director) has filed a Form 4 on Cue Biopharma, Inc.|
Txns:
| Granted 10,000 options to buy
@ $12.36, valued at
$123.6k
|
|
| 08/13/2020 |
4
| DRISCOLL FREDERICK W (Director) has filed a Form 4 on NantKwest, Inc.|
Txns:
| Sold 50,000 shares
@ $10.224, valued at
$511.2k
Sold 10,000 shares
@ $9.9787, valued at
$99.8k
Sold 5,300 shares
@ $10.7669, valued at
$57.1k
|
|
| 07/07/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/25/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/11/2020 |
4
| DRISCOLL FREDERICK W (Director) has filed a Form 4 on NantKwest, Inc.|
Txns:
| Granted 100,000 options to buy
@ $6.21, valued at
$621k
|
|
| 01/06/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/20/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/03/2019 |
4
| DRISCOLL FREDERICK W (Director) has filed a Form 4 on MEI Pharma, Inc.|
Txns:
| Granted 40,000 options to buy
@ $2.52, valued at
$100.8k
|
|
| 06/14/2019 |
4
| DRISCOLL FREDERICK W (Director) has filed a Form 4 on Cellectar Biosciences, Inc.|
Txns:
| Granted 6,500 options to buy
@ $2.15, valued at
$14k
|
|
| 06/07/2019 |
4
| DRISCOLL FREDERICK W (Director) has filed a Form 4 on NantKwest, Inc.|
Txns:
| Granted 92,592 shares
@ $0 |
|
| 01/03/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/15/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/16/2018 |
4
| DRISCOLL FREDERICK W (Director) has filed a Form 4 on MEI Pharma, Inc.|
Txns:
| Granted 40,000 options to buy
@ $4.28, valued at
$171.2k
|
|
| 06/27/2018 |
4
| DRISCOLL FREDERICK W (Director) has filed a Form 4 on Cue Biopharma, Inc.|
Txns:
| Granted 50,000 options to buy
@ $12.97, valued at
$648.5k
|
|
| 06/11/2018 |
4
| DRISCOLL FREDERICK W (Director) has filed a Form 4 on NantKwest, Inc.|
Txns:
| Granted 27,322 shares
@ $0 |
|
| 02/26/2018 |
4
| DRISCOLL FREDERICK W (Director) has filed a Form 4 on MEI Pharma, Inc.|
Txns:
| Granted 33,333 options to buy
@ $2.19, valued at
$73k
|
|
| 09/20/2017 |
4
| DRISCOLL FREDERICK W (Director) has filed a Form 4 on NantKwest, Inc.|
Txns:
| Granted 54,621 shares
@ $0 |
|
| 06/01/2017 |
4
| DRISCOLL FREDERICK W (Director) has filed a Form 4 on Cellectar Biosciences, Inc.|
Txns:
| Granted 10,000 options to buy
@ $1.74, valued at
$17.4k
|
|
| 03/24/2017 |
4
| DRISCOLL FREDERICK W (CFO) has filed a Form 4 on Flexion Therapeutics Inc |
| 03/02/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/27/2016 |
4
| DRISCOLL FREDERICK W (CFO) has filed a Form 4 on Flexion Therapeutics Inc |
|
|
|